Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @WilliamOhMD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @WilliamOhMD
-
William Oh MD proslijedio/la je Tweet
Individualized therapy in metastatic
#ProstateCancer: current options, patient cases, and the latest evidence. CME dinner symposium with@williamohmd,@neerajaiims, Matthew R. Smith, MD, PhD, and Evan Y. Yu, MD: http://bit.ly/2020Prostate#GU20@PeerViewHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
William Oh MD proslijedio/la je Tweet
"These voting results from a panel of
#prostatecancer experts can help clinicians and patients navigate controversial areas of advanced prostate management." Quote by@TischCancer Get your copy
https://www.europeanurology.com/article/S0302-2838(20)30048-8/fulltext …
@EUplatinum@Els_Urology@urotoday#openaccesspic.twitter.com/YVEB6s0lbA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
William Oh MD proslijedio/la je Tweet
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
@apccc19@Silke_Gillessen@AOmlin@onco_uroloog@AlbertoBossial@Prof_IanD@mattsydes@ChrisSweens1 https://www.europeanurology.com/article/S0302-2838(20)30048-8/fulltext …#apccc19#prostatecancerpic.twitter.com/gYBRE5nSnV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Well that explains it....https://www.nytimes.com/2020/01/22/science/gray-hair-stress.html?smid=nytcore-ios-share … via
@NYTimesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
William Oh MD proslijedio/la je Tweet
Saddened by real world chart review of
#EGFR pts@TheUSONetwork from 2015-17 era: post-1L erlotinib, only 19% tested for T790M, only 26% got ANY 2L therapy. That's 74% with no additional rx other than 1st EGFR TKI!
We must do better. @EGFRResisters#LCSM https://www.ncbi.nlm.nih.gov/pubmed/31955357Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks for highlighting this topic! It’s definitely a tricky area with little evidence-based guidance.https://twitter.com/urotoday/status/1219682334959685632 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks
@charlesryanmd for exploring our work. It’s always great to speak with you about research!https://twitter.com/charlesryanmd/status/1219634380567666688 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
William Oh MD proslijedio/la je Tweet
The chalk talk; my own personal two cents... 1. The goal of a chalk talk is not to show how much you know, or to show all the ideas and projects you can think or or actually accomplish
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
William Oh MD proslijedio/la je Tweet
It is now interview season! a few thoughts for those going on job interviews for lab based PI positions. 1) Get there the night before the interview, even if no dinner. If no dinner scheduled and you have a friend there, go out for a bite and get the real scoop
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
William Oh MD proslijedio/la je Tweet
Here’s the bottom line: $297 million budget boost for
@theNCI in FY 2020 = we are extending paylines and anticipate funding more than 125 additional competing awards this fiscal year than we did in FY 2019. More detail in today’s “Bottom Line” blog post:https://www.cancer.gov/grants-training/nci-bottom-line-blog/2020/fy-2020-budget-boost-for-nci …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
William Oh MD proslijedio/la je Tweet
“Precision oncology has had some major successes.” “And yet, the overall effect of precision medicine on care for patients with cancer has been modest.”
@Cutler_econ in @JAMA_currenthttps://jamanetwork.com/journals/jama/fullarticle/2758586 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
William Oh MD proslijedio/la je Tweet
Where are
#ProstateCancer cells in biochemical recurrent disease? Dr.Ken Pienta@pienta_brady@brady_urology reviews emerging PET data suggesting that most pts have Lymph Node based disease in early BCR (not bone which is the site for most overt mets) Implications for therapy?pic.twitter.com/deXXXFdLRP
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
William Oh MD proslijedio/la je Tweet
The prospective clinical MSKCC NGS cohort is now >50,000 samples sequenced. Thanks to the hundreds of physicians, laboratory technicians, data scientists, nurses and support staff
@sloan_kettering who have made this initiative possible. A few thoughts on what we have learned.pic.twitter.com/9ra4tuqUg7
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
William Oh MD proslijedio/la je Tweet
Pharma glorifying data mining and "real world evidence" to sidestep clinical trials, and indications of
@US_FDA in support w/#cancer drugs approvals https://www.wsj.com/articles/drugmakers-turn-to-data-mining-to-avoid-expensive-lengthy-drug-trials-11577097000?mod=searchresults&page=1&pos=1 … by@Loftus, Front page@WSJ w/@jsross119 Hmmm, a lot of@flatironhealth herepic.twitter.com/bKZkloUmuK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
William Oh MD proslijedio/la je Tweet
Chest CT screening came onto the scene several years ago with a proven survival benefit but remains woefully underutilitized. Let’s hope in the next decade we see chest CT screening adopted takes its place alongside colonoscopy, mammography, etc as a clear std of care.
#LCSMHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Still so much to learn re pathogenic germline mutations vs VUS. A sobering article.https://apple.news/Ap2sanVeJRkatMHZ2NLBF-Q …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Honored to host Dr Kanti Rai
@NorthwellHealth for @TischCancer Heme Onc Grand Rounds @IcahnMountSinai! He gave a timely update on CLL including many new therapies.pic.twitter.com/7KMUcpAUmJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Marcellino will be joining
@TischCancer@IcahnMountSinai as Assistant Professor next month!https://twitter.com/IcahnMountSinai/status/1207065448891789313 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.